WAT SON 406 (Lisinopril 5 mg)

Pill imprint WAT SON 406 has been identified as Lisinopril 5 mg.

Lisinopril is used in the treatment of high blood pressure; diabetic kidney disease; migraine prevention; alport syndrome; coronary artery disease (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WAT SON 406

Lisinopril 5 mg WAT SON 406 Front
Lisinopril 5 mg WAT SON 406 Back
Lisinopril 5 mg WAT SON 406
Lisinopril 5 mg WAT SON 406
Lisinopril
Imprint:
WAT SON
406
Strength:
5 mg
Color:
White
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0406
Inactive Ingredients:
silicon dioxide
calcium phosphate dihydrate dibasic
magnesium stearate
mannitol
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0348 McKesson Packaging Services

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)